ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,649Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 3734

$1.94M Total Retail Price of All Prescriptions

Rank: 7 out of 3734

1,007 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,007 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 1,007 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 26,771 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 1,002 859 1 7
LEVOTHYROXINE SODIUM 994 878 2 2
LISINOPRIL 982 793 3 3
SIMVASTATIN 890 681 4 1
OMEPRAZOLE 841 670 5 4
METOPROLOL TARTRATE 822 674 6 6
POTASSIUM CHLORIDE 742 647 7 19
CARVEDILOL 698 631 8 30
METFORMIN HCL 608 523 9 8
WARFARIN SODIUM 582 491 10 10
DIGOXIN 578 532 11 43
AMLODIPINE BESYLATE 531 461 12 5
PRAVASTATIN SODIUM 485 421 13 15
CLOPIDOGREL 450 395 14 23
ATORVASTATIN CALCIUM 419 388 15 11
TAMSULOSIN HCL 383 370 16 29
HYDROCODONE-ACETAMINOPHEN 382 293 S3 17 12
PANTOPRAZOLE SODIUM 382 354 17 22
TRAMADOL HCL 361 310 19 20
GABAPENTIN 346 251 20 17
CITALOPRAM HBR 335 300 21 16
PLAVIX 325 297 22 39
CELEBREX 304 273 23 69
KLOR-CON M20 297 237 24 48
ALLOPURINOL 286 258 25 33
ADVAIR DISKUS 275 205 26 35
DIOVAN 272 247 27 31
DONEPEZIL HCL 271 271 28 25
MELOXICAM 269 220 29 52
SPIRIVA 250 212 30 40
BUMETANIDE 248 211 31 78
ATENOLOL 236 206 32 13
LANTUS 231 154 33 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 228 192 34 27
GLYBURIDE 217 199 R 35 64
ISOSORBIDE MONONITRATE ER 213 192 36 34
NAMENDA 204 204 37 44
CIPROFLOXACIN HCL 201 173 38 77
AMLODIPINE BESYLATE-BENAZEPRIL 196 178 39 56
SUCRALFATE 195 169 40 225
HYDROCHLOROTHIAZIDE 192 156 41 9
CYCLOBENZAPRINE HCL 189 146 R 42 87
ALENDRONATE SODIUM 187 185 43 26
NEXIUM 182 167 44 36
SERTRALINE HCL 181 164 45 18
QUETIAPINE FUMARATE 179 152 46 82
RANITIDINE HCL 170 151 47 32
AMOXICILLIN 164 135 48 108
CYMBALTA 161 92 49 67
SPIRONOLACTONE 156 119 50 80
POLYETHYLENE GLYCOL 3350 151 124 51 53
HYDRALAZINE HCL 151 130 51 111
SYNTHROID 146 138 53 47
FLUTICASONE PROPIONATE 146 123 53 46
TRICOR 131 87 55 93
CRESTOR 130 118 56 28
PHENYTOIN SODIUM EXTENDED 130 73 56 149
MIRTAZAPINE 129 117 58 45
HUMALOG 127 116 59 146
METOPROLOL SUCCINATE 125 103 60 14
PREDNISONE 124 111 61 42
ZOLPIDEM TARTRATE 122 119 62 24
PAROXETINE HCL 121 109 63 59
DILTIAZEM 24HR ER 121 109 63 86
TRAZODONE HCL 120 64 65 49
DIOVAN HCT 118 109 66 72
LANTUS SOLOSTAR 116 95 67 102
LOSARTAN POTASSIUM 113 95 68 21
ALBUTEROL SULFATE 108 105 69 128
MECLIZINE HCL 104 104 70 139
SULINDAC 104 58 70 338
VENLAFAXINE HCL ER 103 86 72 84
GLIMEPIRIDE 102 95 73 37
JANUVIA 100 60 74 50
METOLAZONE 99 87 75 174
FLUOXETINE HCL 99 99 75 61
IPRATROPIUM BROMIDE 98 97 77 220
KLOR-CON M10 97 94 78 115
IPRATROPIUM-ALBUTEROL 95 95 79 98
LIPITOR 95 92 79 90
GLIPIZIDE 92 73 81 57
DOXYCYCLINE HYCLATE 91 71 82 147
TRIAMCINOLONE ACETONIDE 91 80 82 131
CARBIDOPA-LEVODOPA 90 90 84 92
PROPRANOLOL HCL 89 89 85 126
AVODART 88 88 86 209
NITROFURANTOIN MONO-MACRO 85 76 87 196
AMITRIPTYLINE HCL 84 74 R 88 94
BENICAR 83 83 89 107
CEFUROXIME 83 65 89 168
QUINAPRIL HCL 82 71 91 74
NOVOLOG 81 46 92 112
HUMULIN 70-30 80 73 93 229
DETROL LA 79 79 94 153
INSULIN SYRINGE 78 75 95 109
ONGLYZA 77 65 96 211
AZITHROMYCIN 73 55 97 38
GEMFIBROZIL 70 39 98 114
BENICAR HCT 69 55 99 167
FENTANYL 69 69 S2 99 65
LANSOPRAZOLE 68 55 101 155
PEN NEEDLE 66 57 102 152
NITROGLYCERIN PATCH 66 54 102 171
ESCITALOPRAM OXALATE 64 56 104 68
RAMIPRIL 62 62 105 91
ZETIA 61 50 106 55
TRIAMTERENE-HCTZ 60 60 107 73
EVISTA 60 48 107 130
DICLOFENAC SODIUM 60 19 107 127
HYDROXYZINE HCL 59 50 R 110 208
SEROQUEL 59 44 110 161
LEVETIRACETAM 58 44 112 105
VALPROIC ACID 56 23 113 223
LOSARTAN-HYDROCHLOROTHIAZIDE 55 49 114 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 32 114 117
ROPINIROLE HCL 55 52 114 118
LOVASTATIN 54 42 117 41
GLIPIZIDE XL 54 48 117 85
BUPROPION XL 53 39 119 250
ENALAPRIL MALEATE 53 53 119 63
ACTOS 53 47 119 110
OXYCODONE-ACETAMINOPHEN 53 36 S2 119 51
EXELON 53 53 119 150
FENOFIBRATE 52 31 124 81
DILTIAZEM 24HR CD 52 43 124 97
TORSEMIDE 51 35 126 160
PRADAXA 51 51 126 205
LABETALOL HCL 50 49 128 176
ACTONEL 50 41 128 188
NAPROXEN 50 47 128 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.